Dementia Risk Persists Even After Age 90, Study Shows
Reaching the age of 90 without dementia does not completely eliminate an individual’s susceptibility to cognitive decline, according to a longitudinal study published in The Lancet Healthy Longevity. Researchers tracking older adults found that advanced age alone does not shield populations from neurodegenerative pathology, with risks varying substantially across demographic and genetic lines.
- Women aged 90 and older face nearly double the risk of developing dementia compared to men in the same age bracket, according to data from the LifeAfter90 study.
- Racial and ethnic disparities persist into the tenth decade of life, with Black participants demonstrating a 75% higher risk of dementia compared to Asian participants.
- The APOE4 genetic variant increases dementia risk primarily among men and nearly doubles that risk among Black participants, while the APOE2 variant retains its protective effect even past age 90.
As global life expectancy climbs, demographic projections estimate that approximately 230 million people worldwide will reach age 90 or older by the year 2100. This demographic shift intensifies the need for precise epidemiological data regarding late-life brain health. Funded by research initiatives examining aging trajectories, the LifeAfter90 study led by researchers at UC Davis Health and Kaiser Permanente has tracked a diverse cohort of nonagenarians since 2018 to evaluate how cognitive health changes in the extreme elderly.
Demographic Disparities in Nonagenarian Cohorts
The analysis incorporated medical records and assessments from more than 800 participants with an average age of 92. By evaluating a racially and ethnically diverse population, researchers identified that health disparities established earlier in life continue unabated into advanced old age. Rachel Whitmer, professor of public health sciences and neurology at UC Davis Health and senior author of the study, noted that while prior research established distinct risk profiles for individuals aged 65 and older, the question of whether those patterns held true past 90 remained largely unanswered.
Participants who identified as Black or Hispanic experienced significantly higher rates of cognitive decline compared to white and Asian participants. Hillary Colbeth, a postdoctoral scholar in public health sciences at UC Davis and first author of the article, emphasized the persistence of these gaps.
The Evolving Role of Alzheimer’s Risk Genes
Genetic factors also shape late-life neurological outcomes. Investigators examined the role of the APOE gene, which is strongly linked to Alzheimer’s disease pathogenesis. The APOE2 variant acts as a protective factor, reducing the probability of developing the condition. Data from the study confirmed that this protective advantage remains potent past age 90, with carriers showing a 60% lower risk of dementia.
Conversely, the APOE4 variant presents a more complex clinical picture. Across the entire study population, the variant did not uniformly elevate overall dementia incidence. However, subgroup analyses revealed notable interactions with sex and race. Among male participants, APOE4 correlated with an elevated risk, while Black participants carrying the variant faced nearly double the risk of developing dementia.
Future Trajectories in Cognitive Epidemiology
Understanding the exact intersection of genetics, systemic health disparities, and advanced aging remains a primary objective for clinical researchers.
*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*